Daniel S ONeil
Overview
Explore the profile of Daniel S ONeil including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
257
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bhangdia K, Natarajan A, Rudolfson N, Verguet S, Castro M, Dusengimana J, et al.
BMC Cancer
. 2025 Jan;
25(1):146.
PMID: 39865262
Background: Butaro Cancer Center of Excellence (BCCOE) was founded to serve Rwanda's rural low-income population, providing subsidized cancer diagnosis and treatment with transport stipends for the lowest-income patients. We examined...
2.
Dubner J, Neugut A, Joffe M, ONeil D, Ayeni O, Chen W, et al.
Lancet Glob Health
. 2024 Nov;
12(12):e1993-e2002.
PMID: 39577973
Background: Breast cancer is the most common malignancy diagnosed among women in South Africa, with the aggressive triple-negative subtype comprising approximately 15% of breast cancers in this population. South Africa...
3.
ONeil D, Blanchard C, Joffe M, Antoni M, Ream M, Mmoledi K, et al.
Res Sq
. 2024 Jul;
PMID: 38978566
Purpose: We aimed to evaluate for associations between HIV status, psychosocial factors, and adjuvant endocrine therapy (AET) adherence in South African (SA) women with estrogen receptor positive (ER+) breast cancer...
4.
5.
ONeil D, Martei Y, Crew K, Castillo B, Costa P, Lim T, et al.
JAMA Netw Open
. 2023 Dec;
6(12):e2346223.
PMID: 38051529
Importance: Patients with breast cancer and comorbid HIV experience higher mortality than other patients with breast cancer. Objective: To compare time to cancer treatment initiation and relative dose intensity (RDI)...
6.
Mapanga W, Ayeni O, Chen W, Jacobson J, Neugut A, Ruff P, et al.
PLOS Glob Public Health
. 2023 Oct;
3(10):e0002432.
PMID: 37874786
The South African Breast Cancer and HIV Outcomes prospective cohort (SABCHO) study was established to investigate survival determinants among HIV-positive and HIV-negative SA women with breast cancer. This paper describes...
7.
Tshabalala G, Blanchard C, Mmoledi K, Malope D, ONeil D, Norris S, et al.
PLOS Glob Public Health
. 2023 May;
3(5):e0001826.
PMID: 37159437
Low-and-middle income countries (LMICs) contribute approximately 70% of global cancer deaths, and the cancer incidence in these countries is rapidly increasing. Sub-Saharan African (SSA) countries, including South Africa (SA), bear...
8.
Chiwambutsa S, Ayeni O, Kapungu N, Kanji C, Thelingwani R, Chen W, et al.
Clin Pharmacol Ther
. 2023 Apr;
114(1):127-136.
PMID: 37042388
Clinical outcomes of tamoxifen (TAM) treatment show wide interindividual variability. Comedications and genetic polymorphisms of enzymes involved in TAM metabolism contributes to this variability. Drug-drug and drug-gene interactions have seldom...
9.
ONeil D, Ayeni O, Farrow H, Chen W, Demetriou G, Buccimazza I, et al.
Oncologist
. 2023 Mar;
28(10):e921-e929.
PMID: 36943395
Introduction: In the South African Breast Cancer and HIV Outcomes (SABCHO) study, we previously found that breast cancer patients living with HIV and treated with neoadjuvant chemotherapy achieve lower rates...
10.
Mapanga W, Norris S, Craig A, Ayeni O, Chen W, Jacobson J, et al.
PLoS One
. 2023 Feb;
18(2):e0281916.
PMID: 36795733
Objective: In low- and middle-income countries (LMICs), advanced-stage diagnosis of breast cancer (BC) is common, and this contributes to poor survival. Understanding the determinants of the stage at diagnosis will...